ID CP1A1_CAVPO Reviewed; 516 AA. AC Q06367; DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 27-MAR-2024, entry version 154. DE RecName: Full=Cytochrome P450 1A1; DE EC=1.14.14.1 {ECO:0000250|UniProtKB:P04798}; DE AltName: Full=CYPIA1; DE AltName: Full=Cytochrome P450 form 6; DE AltName: Full=Cytochrome P450-C; DE AltName: Full=Cytochrome P450-P1; DE AltName: Full=Hydroperoxy icosatetraenoate dehydratase; DE EC=4.2.1.152 {ECO:0000250|UniProtKB:P04798}; GN Name=CYP1A1; OS Cavia porcellus (Guinea pig). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Hystricomorpha; Caviidae; OC Cavia. OX NCBI_TaxID=10141; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=Hartley; TISSUE=Liver; RX PubMed=8241264; DOI=10.1016/0167-4781(93)90150-c; RA Ohgiya S., Ishizaki K., Shinriki N.; RT "Molecular cloning of guinea pig CYP1A1: complete primary structure and RT fast mobility of expressed protein on electrophoresis."; RL Biochim. Biophys. Acta 1216:237-244(1993). RN [2] RP PROTEIN SEQUENCE OF 1-24. RC TISSUE=Liver; RX PubMed=3718958; DOI=10.1021/bi00357a015; RA Cheng K.C., Park S.S., Krutzsch H.C., Grantham P.H., Gelboin H.V., RA Friedman F.K.; RT "Amino-terminal sequence and structure of monoclonal antibody RT immunopurified cytochromes P-450."; RL Biochemistry 25:2397-2402(1986). CC -!- FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of CC various endogenous substrates, including fatty acids, steroid hormones CC and vitamins. Mechanistically, uses molecular oxygen inserting one CC oxygen atom into a substrate, and reducing the second into a water CC molecule, with two electrons provided by NADPH via cytochrome P450 CC reductase (CPR; NADPH-ferrihemoprotein reductase). Catalyzes the CC hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic CC activity for the formation of hydroxyestrogens from estrone (E1) and CC 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring CC hydroxylated E1 and E2 at the C15alpha and C16alpha positions. Displays CC different regioselectivities for polyunsaturated fatty acids (PUFA) CC hydroxylation. Catalyzes the epoxidation of double bonds of certain CC PUFA. Converts arachidonic acid toward epoxyeicosatrienoic acid (EET) CC regioisomers, 8,9-, 11,12-, and 14,15-EET, that function as lipid CC mediators in the vascular system. Displays an absolute CC stereoselectivity in the epoxidation of eicosapentaenoic acid (EPA) CC producing the 17(R),18(S) enantiomer. May play an important role in CC all-trans retinoic acid biosynthesis in extrahepatic tissues. Catalyzes CC two successive oxidative transformation of all-trans retinol to all- CC trans retinal and then to the active form all-trans retinoic acid. May CC also participate in eicosanoids metabolism by converting hydroperoxide CC species into oxo metabolites (lipoxygenase-like reaction, NADPH- CC independent). {ECO:0000250|UniProtKB:P04798}. CC -!- CATALYTIC ACTIVITY: CC Reaction=an organic molecule + O2 + reduced [NADPH--hemoprotein CC reductase] = an alcohol + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:17149, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:30879, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:142491; EC=1.14.14.1; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17151; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone + O2 + reduced [NADPH--hemoprotein reductase] = 2- CC hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:47208, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:1156, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:17263, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47209; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone + O2 + reduced [NADPH--hemoprotein reductase] = 4- CC hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:47292, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:17263, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:87602; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47293; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone + O2 + reduced [NADPH--hemoprotein reductase] = CC 6alpha-hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:47308, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:17263, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:87605; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47309; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone + O2 + reduced [NADPH--hemoprotein reductase] = CC 15alpha-hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:47312, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:17263, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:87618; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47313; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone + O2 + reduced [NADPH--hemoprotein reductase] = CC 16alpha-hydroxyestrone + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:47204, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:776, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:17263, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47205; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] CC = 2-hydroxy-17beta-estradiol + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:47212, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16469, CC ChEBI:CHEBI:28744, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47213; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] CC = 4-hydroxy-17beta-estradiol + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:47280, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16469, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:62845; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47281; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] CC = 6alpha-hydroxy-17beta-estradiol + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:47284, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16469, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:62847; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47285; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] CC = 7alpha-hydroxy-17beta-estradiol + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:47288, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16469, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87598; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47289; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17beta-estradiol + O2 + reduced [NADPH--hemoprotein reductase] CC = 15alpha-hydroxy-17beta-estradiol + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:47276, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16469, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:87593; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47277; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z)-eicosatrienoate + O2 + reduced [NADPH--hemoprotein CC reductase] = 19-hydroxy-(5Z,8Z,11Z)-eicosatrienoate + H(+) + H2O + CC oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:50076, CC Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:78043, ChEBI:CHEBI:132024; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50077; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 16-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49972, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:132019; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49973; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 17-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49968, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:132016; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49969; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 18-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:39811, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:63590; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39812; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 19-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:39759, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:76627; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39760; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 19-hydroxy-(5Z,8Z,11Z,14Z,17Z)- CC eicosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:39787, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:58562, CC ChEBI:CHEBI:76636; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39788; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (8R,9S)-epoxy-(5Z,11Z,14Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49884, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131975; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49885; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (11R,12S)-epoxy-(5Z,8Z,14Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49880, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131970; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49881; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (14S,15R)-epoxy-(5Z,8Z,11Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49856, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131964; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49857; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (14R,15S)-epoxy-(5Z,8Z,11Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49860, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131965; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49861; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (17R,18S)-epoxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:39779, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:58562, CC ChEBI:CHEBI:76634; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39780; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (19S,20R)-epoxy-(4Z,7Z,10Z,13Z,16Z)- CC docosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:52124, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:77016, CC ChEBI:CHEBI:136411; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52125; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (19R,20S)-epoxy-(4Z,7Z,10Z,13Z,16Z)- CC docosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:52120, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:77016, CC ChEBI:CHEBI:136410; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52121; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=all-trans-retinol + O2 + reduced [NADPH--hemoprotein CC reductase] = all-trans-retinal + H(+) + 2 H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:42092, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17336, CC ChEBI:CHEBI:17898, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42093; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=all-trans-retinal + O2 + reduced [NADPH--hemoprotein CC reductase] = all-trans-retinoate + 2 H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:42088, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17898, CC ChEBI:CHEBI:35291, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42089; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(13S)-hydroperoxy-(9Z,11E)-octadecadienoate = 13-oxo-(9Z,11E)- CC octadecadienoate + H2O; Xref=Rhea:RHEA:48716, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:57466, ChEBI:CHEBI:90781; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48717; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate = 12-oxo- CC (5Z,8Z,10E,14Z)-eicosatetraenoate + H2O; Xref=Rhea:RHEA:37947, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:57444, ChEBI:CHEBI:75231; CC EC=4.2.1.152; Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37948; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate = 15-oxo- CC (5Z,8Z,11Z,13E)-eicosatetraenoate + H2O; Xref=Rhea:RHEA:48636, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:57410, ChEBI:CHEBI:57446; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48637; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate = 5-oxo- CC (6E,8Z,11Z,14Z)-eicosatetraenoate + H2O; Xref=Rhea:RHEA:48632, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:57450, ChEBI:CHEBI:65342; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48633; CC Evidence={ECO:0000250|UniProtKB:P04798}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250}; CC -!- PATHWAY: Steroid hormone biosynthesis. {ECO:0000250|UniProtKB:P04798}. CC -!- PATHWAY: Lipid metabolism; fatty acid metabolism. CC {ECO:0000250|UniProtKB:P04798}. CC -!- PATHWAY: Cofactor metabolism; retinol metabolism. CC {ECO:0000250|UniProtKB:P04798}. CC -!- SUBUNIT: Interacts with cytosolic chaperones HSP70 and HSP90; this CC interaction is required for initial targeting to mitochondria. CC Interacts (via mitochondrial targeting signal) with TOMM40 (via N- CC terminus); this interaction is required for translocation across the CC mitochondrial outer membrane. {ECO:0000250|UniProtKB:P00185}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P00185}. Mitochondrion inner membrane CC {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P00185}. Microsome membrane CC {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein CC {ECO:0000250|UniProtKB:P00185}. Cytoplasm CC {ECO:0000250|UniProtKB:P00185}. CC -!- TISSUE SPECIFICITY: Constitutively expressed in liver. CC -!- INDUCTION: By 3-methylcholanthrene (3MC). CC -!- MISCELLANEOUS: Constitutive expression of this enzyme in liver may be CC related to the sensitivity of guinea pig to TCDD. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D11043; BAA01794.1; -; mRNA. DR PIR; S43414; S43414. DR RefSeq; NP_001166411.1; NM_001172940.1. DR RefSeq; XP_013000999.1; XM_013145545.1. DR AlphaFoldDB; Q06367; -. DR SMR; Q06367; -. DR STRING; 10141.ENSCPOP00000014064; -. DR GlyCosmos; Q06367; 1 site, No reported glycans. DR Ensembl; ENSCPOT00000015748.3; ENSCPOP00000014064.2; ENSCPOG00000015596.4. DR GeneID; 100135512; -. DR KEGG; cpoc:100135512; -. DR CTD; 1543; -. DR VEuPathDB; HostDB:ENSCPOG00000015596; -. DR eggNOG; KOG0156; Eukaryota. DR GeneTree; ENSGT00950000183037; -. DR HOGENOM; CLU_001570_22_0_1; -. DR InParanoid; Q06367; -. DR OMA; DPRAYWQ; -. DR OrthoDB; 2900138at2759; -. DR TreeFam; TF105095; -. DR UniPathway; UPA00199; -. DR UniPathway; UPA00912; -. DR Proteomes; UP000005447; Unassembled WGS sequence. DR Bgee; ENSCPOG00000015596; Expressed in liver and 3 other cell types or tissues. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005743; C:mitochondrial inner membrane; ISS:UniProtKB. DR GO; GO:0008391; F:arachidonic acid monooxygenase activity; IEA:Ensembl. DR GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC. DR GO; GO:0101020; F:estrogen 16-alpha-hydroxylase activity; ISS:UniProtKB. DR GO; GO:0101021; F:estrogen 2-hydroxylase activity; ISS:UniProtKB. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0030544; F:Hsp70 protein binding; ISS:UniProtKB. DR GO; GO:0051879; F:Hsp90 protein binding; ISS:UniProtKB. DR GO; GO:0106256; F:hydroperoxy icosatetraenoate dehydratase activity; IEA:UniProtKB-EC. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0120319; F:long-chain fatty acid omega-1 hydroxylase activity; IEA:Ensembl. DR GO; GO:0102033; F:long-chain fatty acid omega-hydroxylase activity; IEA:Ensembl. DR GO; GO:0070576; F:vitamin D 24-hydroxylase activity; IEA:Ensembl. DR GO; GO:0009308; P:amine metabolic process; IEA:Ensembl. DR GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl. DR GO; GO:0008210; P:estrogen metabolic process; ISS:UniProtKB. DR GO; GO:0046483; P:heterocycle metabolic process; IEA:Ensembl. DR GO; GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl. DR GO; GO:0002933; P:lipid hydroxylation; IEA:Ensembl. DR GO; GO:0001676; P:long-chain fatty acid metabolic process; IEA:Ensembl. DR GO; GO:0009636; P:response to toxic substance; IEA:Ensembl. DR GO; GO:0042572; P:retinol metabolic process; ISS:UniProtKB. DR GO; GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0009404; P:toxin metabolic process; IEA:Ensembl. DR GO; GO:0006805; P:xenobiotic metabolic process; IEA:Ensembl. DR CDD; cd20676; CYP1A; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR008066; Cyt_P450_E_grp-I_CYP1. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24289:SF18; CYTOCHROME P450 1A2; 1. DR PANTHER; PTHR24289; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR01683; EP450ICYP1A. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 1: Evidence at protein level; KW Cytoplasm; Direct protein sequencing; Endoplasmic reticulum; Glycoprotein; KW Heme; Iron; Lipid biosynthesis; Lipid metabolism; Lyase; Membrane; KW Metal-binding; Microsome; Mitochondrion; Mitochondrion inner membrane; KW Monooxygenase; Oxidoreductase; Reference proteome; Steroid biosynthesis. FT CHAIN 1..516 FT /note="Cytochrome P450 1A1" FT /id="PRO_0000051626" FT REGION 25..36 FT /note="Mitochondrial targeting signal" FT /evidence="ECO:0000250|UniProtKB:P00185" FT BINDING 220 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 453 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250" FT CARBOHYD 63 FT /note="O-linked (GlcNAc) serine" FT /evidence="ECO:0000250" FT CONFLICT 2 FT /note="Missing (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 16 FT /note="C -> W (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 516 AA; 58571 MW; 026DD4DCAB6E39BA CRC64; MSTSAMELLL TATIFCLVLW VVRIFRPQVP KGLKSPPGPW GWPLIGHMLT LGKNPHLALT RLSARYGDVL QIRIGSTPVV VLSGLDTIRQ ALVRQGDDFK GRPDLYSFTF ISDGQSMTFN PDSGPVWAAR RRLAQSALKS FSVASDPASV SSCYLEEHVK KEAEYLIKKF QELMAGPGHF DPYRYVVVSV ANVISAICFG QRYSHDDQQL LELIDLNNEF GEVTGSGNPS DFIPILRYLP SATMDTFKDL NRRFSVFIQK MIKEHYKTFE KGHIRDITDS LIEHCQDRKL DKNANIQISD QKIIGIVLDL FGAGFDTITT AISWSLLYLV MNPRIQKKIQ EELDTVIGRE RQPQLADRPK LPYMEAFISE VFRYSSFMPF TIPHSTTKDT SLNGFYIPKG CCIFVNQWQI NHDQKLWGDP SVFRPERFLS PDGTVDKALS EKVTIFGLGK RRCLGEVIGR WEVFLFLAIL LQQLEFSTSP GVKIDMTPIY GLTMKYSRCE HFQAQTRPFV LKCPEA //